Our analysis revealed a notable reduction in CD8+ T cells, NKT cells, and tumor IFNγ levels in EGFRdel/DUSP22 KO tumors (Figs. 3D, E, F, and S3C). This evidence concerns the gene CD8A and neoplasm.